Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
O'Brien
C F
CF
Department of Medical Affairs, Elan Pharmaceuticals, South San Francisco, California 94080, USA.
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D004421:Dystonia / Q000188:drug therapy*; D005684:Gait / Q000187:drug effects*; D020233:Gait Disorders, Neurologic / Q000188:drug therapy*; D006801:Humans; D009121:Muscle Denervation / Q000379:methods; D009128:Muscle Spasticity / Q000188:drug therapy
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins